Dr Marianne Brodmann (Professor of Vascular Medicine, Medical University of Graz, Graz, Austria) discusses the challenges, treatment and developments in antithrombotic therapy in patients with lower extremity arterial disease (LEAD).
Filmed at ESC 2018, Munich.
View more content here.
Speaker Disclosure: Dr Marianne Brodmann has nothing to disclose in relation to this video interview.
1. Please describe the current challenges of treating lower extremity arterial disease (LEAD) compared with other forms of atherosclerotic cardiovascular disease? (0:09)
2. How do you currently treat patients with LEAD? (1:32)
3. What are the treatment goals for patients receiving antithrombotic therapy to treat LEAD? (2:29)
4. What recent developments have there been in the treatment of LEAD, particularly concerning the use of antithrombotic therapy? (3:13)
5. What further research is currently ongoing and planned to assess the benefit of antithrombotic therapy in LEAD? (4:09)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.
Share this Video
Related Videos In Cardiovascular Disease
William Schulyer-Jones, ACC 2021 – Findings from the ADAPTIVE study
We were delighted to speak with Dr William Schulyer-Jones (Associate Professor of Medicine, Duke University School of Medicine, Durham, NC, USA) about the findings of the ADAPTABLE STUDY, a large randomized study assessing the benefits and long-term effectiveness of aspirin dosage (81 mg vs. 325mg) for patients with cardiovascular disease. Abstract title: Aspirin Dosing: A […]
Gustavo Samaja, ESC 2020 – Myocardial Infarction with no Obstructive Coronary Arteries
We spoke to Dr Gustavo Samaja (Policlinico Bancario, Buenos Aires, Argentina) about myocardial infarction with no obstructive coronary arteries (MINOCA), and especially its prevalence and importance during the COVID-19 pandemic. Questions Could you give us a brief overview of myocardial infarction with no obstructive coronary arteries (MINOCA)? (0:33) How prevalent is MINOCA and what […]
David Playford, ESC 2020 – Diastolic Function and Mortality Part 1
We spoke to Professor David Playford (University of Notre Dame, Perth, Australia) regarding diastolic function and dysfunction, the National Echo Database Australia (NEDA), and then focused on his recent study on diastolic function and mortality. Questions What are the prognostic implications of diastolic dysfunction? (0:07) How do you classify patients by diastolic function? (1:18) […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!